Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Colaboración

Año: 2015

Perez-Molina, JA; Rubio, R; Rivero, A; Pasquau, J; Suarez-Lozano, I; Riera, M; Estebanez, M; Santos, J; Sanz-Moreno, J; Troya, J; Marino, A; Antela, A; Navarro, J; Esteban, H; Moreno, S

Título: LANCET INFECTIOUS DISEASES

• D1